1-844-762-9522 info@rdxbioscience.com

KENILWORTH, N.J.–RDx BioScience(RDx), providers of high-quality laboratory and genomic testing, and evidence-based research designed to direct patient care for clinicians, employers and payers, announces that Scott Howell, DO, MPH&TM, CPE, chief medical officer, RDx, will present “Alternative Payment Models: The Future for Addiction Medicine?” at the Alcoholism & Substance Abuse Providers (ASAP) of New York state conference, Tuesday, Sept. 19, 2017, 1:30-3 p.m., Buffalo Niagara Convention Center, Buffalo, New York.

“This discussion about the creation and development of alternative payment models will give attendees a deeper understanding of how such payments will impact addiction medicine in years to come,” says Dr. Howell. “Emerging payment models, such as bundled payments, must be developed alongside prescriber education programs to help primary care providers address opioid use and abuse nationwide.”

In 2015, opioids accounted for more than two-thirds of all drug overdose deaths in the U.S. — 15.6 percent more than the previous year — and drug overdose deaths nearly tripled between 1999 and 2014. Despite policy changes and education programs, opioid prescribing remains a high-priority concern for all stakeholders in pain management.

RDx has underwritten an educational grant to support a Mandatory Prescriber Education Course in New York state, and will replicate opportunities throughout the country.

Dr. Howell adds, “ASAP supports organizations, groups and individuals focused on preventing and alleviating the profound personal, social and economic impact of alcohol and substance abuse in New York state. This conference represents an excellent opportunity for thought leaders to work together to end a devastating public health crisis.”

About RDx

RDx is a full-service, high-technology laboratory. We are fast, accurate, and deliver value-based service nationally. RDx is accredited by the College of American Pathologists (CAP) as a certified, full-service medical laboratory. Visithttps://www.rdxbioscience.com/

Media:
CPR for RDx BioScience
Brittany Tedesco, 201.641.1911 x14
btedesco@cpronline.com